{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T01:31:16Z","timestamp":1777167076469,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82173177, No. 82472955, No. 82303311"],"award-info":[{"award-number":["No. 82173177, No. 82472955, No. 82303311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Anti-Cancer Association Young Eagle Program","award":["SACA-CY24B07"],"award-info":[{"award-number":["SACA-CY24B07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07852-5","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:35:20Z","timestamp":1771061720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and immunological significance of tertiary lymphoid structure maturation heterogeneity in brain metastases of lung adenocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Changshuai","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingtao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"2","key":"7852_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jncc.2024.05.001","volume":"4","author":"W Cao","year":"2024","unstructured":"Cao W, Qin K, Li F, Chen W. Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J Natl Cancer Cent Jun. 2024;4(2):128\u201334. https:\/\/doi.org\/10.1016\/j.jncc.2024.05.001.","journal-title":"J Natl Cancer Cent Jun"},{"issue":"3","key":"7852_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jncc.2024.06.005","volume":"4","author":"H Zeng","year":"2024","unstructured":"Zeng H, Zheng R, Sun K, et al. Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study. J Natl Cancer Cent Sep. 2024;4(3):203\u201313. https:\/\/doi.org\/10.1016\/j.jncc.2024.06.005.","journal-title":"J Natl Cancer Cent Sep"},{"issue":"4","key":"7852_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41588-020-0592-7","volume":"52","author":"DJH Shih","year":"2020","unstructured":"Shih DJH, Nayyar N, Bihun I, et al. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nat Genet Apr. 2020;52(4):371\u20137. https:\/\/doi.org\/10.1038\/s41588-020-0592-7.","journal-title":"Nat Genet Apr"},{"issue":"7","key":"7852_CR4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/neuonc\/noad017","volume":"6","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang Y, Chang M, et al. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro Oncol Jul. 2023;6(7):1262\u201374. https:\/\/doi.org\/10.1093\/neuonc\/noad017.","journal-title":"Neuro Oncol Jul"},{"key":"7852_CR5","doi-asserted-by":"publisher","first-page":"217262","DOI":"10.1016\/j.canlet.2024.217262","volume":"28","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang D, Meng B, et al. Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas. Cancer Lett Nov. 2024;28:605:217262. https:\/\/doi.org\/10.1016\/j.canlet.2024.217262.","journal-title":"Cancer Lett Nov"},{"issue":"1","key":"7852_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent Mar. 2024;4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent Mar"},{"issue":"3","key":"7852_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jncc.2025.01.003","volume":"5","author":"Y Ji","year":"2025","unstructured":"Ji Y, Zhang Y, Liu S, et al. The epidemiological landscape of lung cancer: current status, Temporal trend and future projections based on the latest estimates from GLOBOCAN 2022. J Natl Cancer Cent Jun. 2025;5(3):278\u201386. https:\/\/doi.org\/10.1016\/j.jncc.2025.01.003.","journal-title":"J Natl Cancer Cent Jun"},{"issue":"4","key":"7852_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jncc.2025.04.003","volume":"5","author":"W Xu","year":"2025","unstructured":"Xu W, Lu J, Zhang H, Ye D. Decoding the tumor microenvironment: insights into immunotherapy and beyond. J Natl Cancer Cent Aug. 2025;5(4):426\u20138. https:\/\/doi.org\/10.1016\/j.jncc.2025.04.003.","journal-title":"J Natl Cancer Cent Aug"},{"issue":"9","key":"7852_CR9","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","volume":"2","author":"M Lauss","year":"2022","unstructured":"Lauss M, Donia M, Svane IM, Jonsson G. B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? Clin Cancer Res May. 2022;2(9):1751\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1130.","journal-title":"Clin Cancer Res May"},{"issue":"1","key":"7852_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","volume":"32","author":"M Lee","year":"2019","unstructured":"Lee M, Heo SH, Song IH, et al. Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Mod Pathol Jan. 2019;32(1):70\u201380. https:\/\/doi.org\/10.1038\/s41379-018-0113-8.","journal-title":"Mod Pathol Jan"},{"key":"7852_CR11","doi-asserted-by":"publisher","first-page":"155171","DOI":"10.1016\/j.prp.2024.155171","volume":"254","author":"S Dieleman","year":"2024","unstructured":"Dieleman S, Kooreman LFS, van Kuijk SMJ, Zur Hausen A, Smidt ML, Grabsch HI. Germinal centres within tumour positive Sentinel lymph nodes are positively associated with tumour infiltrating lymphocytes and tertiary lymphoid structures in breast cancer. Pathol Res Pract Feb. 2024;254:155171. https:\/\/doi.org\/10.1016\/j.prp.2024.155171.","journal-title":"Pathol Res Pract Feb"},{"issue":"1","key":"7852_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44276-025-00146-1","volume":"28","author":"A Hegoburu","year":"2025","unstructured":"Hegoburu A, Amer M, Frizelle F, Purcell R. B cells and tertiary lymphoid structures in cancer therapy response. BJC Rep May. 2025;28(1):40. https:\/\/doi.org\/10.1038\/s44276-025-00146-1.","journal-title":"BJC Rep May"},{"issue":"2","key":"7852_CR13","doi-asserted-by":"publisher","first-page":"20210146","DOI":"10.1002\/EXP.20210146","volume":"4","author":"F Zhou","year":"2024","unstructured":"Zhou F, Huang L, Li S, et al. From structural design to delivery: mRNA therapeutics for cancer immunotherapy. Exploration (Beijing) Apr. 2024;4(2):20210146. https:\/\/doi.org\/10.1002\/EXP.20210146.","journal-title":"Exploration (Beijing) Apr"},{"issue":"7791","key":"7852_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature Jan. 2020;577(7791):561\u20135. https:\/\/doi.org\/10.1038\/s41586-019-1914-8.","journal-title":"Nature Jan"},{"issue":"6","key":"7852_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer Jun. 2019;19(6):307\u201325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","journal-title":"Nat Rev Cancer Jun"},{"issue":"11","key":"7852_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","volume":"35","author":"MC Dieu-Nosjean","year":"2014","unstructured":"Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH. Tertiary lymphoid structures in cancer and beyond. Trends Immunol Nov. 2014;35(11):571\u201380. https:\/\/doi.org\/10.1016\/j.it.2014.09.006.","journal-title":"Trends Immunol Nov"},{"key":"7852_CR17","doi-asserted-by":"publisher","first-page":"101797","DOI":"10.1016\/j.smim.2023.101797","volume":"69","author":"C Cui","year":"2023","unstructured":"Cui C, Craft J, Joshi NS. T follicular helper cells in cancer, tertiary lymphoid structures, and beyond. Semin Immunol Sep. 2023;69:101797. https:\/\/doi.org\/10.1016\/j.smim.2023.101797.","journal-title":"Semin Immunol Sep"},{"issue":"7","key":"7852_CR18","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest Jul. 2013;123(7):2873\u201392. https:\/\/doi.org\/10.1172\/JCI67428.","journal-title":"J Clin Invest Jul"},{"key":"7852_CR19","doi-asserted-by":"publisher","first-page":"865596","DOI":"10.3389\/fimmu.2022.865596","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zhou J, Xiao Y, et al. CD20(+)CD22(+)ADAM28(+) B cells in tertiary lymphoid structures promote immunotherapy response. Front Immunol. 2022;13:865596. https:\/\/doi.org\/10.3389\/fimmu.2022.865596.","journal-title":"Front Immunol"},{"issue":"3","key":"7852_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s13402-025-01052-x","volume":"48","author":"H Elfving","year":"2025","unstructured":"Elfving H, Yu H, Fessehatsion KK, et al. Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer. Cell Oncol (Dordr) Jun. 2025;48(3):801\u201313. https:\/\/doi.org\/10.1007\/s13402-025-01052-x.","journal-title":"Cell Oncol (Dordr) Jun"},{"key":"7852_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-030-73119-9_3","volume":"1329","author":"MC Dieu-Nosjean","year":"2021","unstructured":"Dieu-Nosjean MC. Tumor-Associated tertiary lymphoid structures: A cancer biomarker and a target for Next-generation immunotherapy. Adv Exp Med Biol. 2021;1329:51\u201368. https:\/\/doi.org\/10.1007\/978-3-030-73119-9_3.","journal-title":"Adv Exp Med Biol"},{"issue":"7791","key":"7852_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature Jan. 2020;577(7791):549\u201355. https:\/\/doi.org\/10.1038\/s41586-019-1922-8.","journal-title":"Nature Jan"},{"key":"7852_CR23","doi-asserted-by":"publisher","unstructured":"Xu W, Lu J, Tian X, et al. Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm (2020). 2024 Jan;5(1):e461. https:\/\/doi.org\/10.1002\/mco2.461.","DOI":"10.1002\/mco2.461"},{"issue":"3","key":"7852_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2217\/imt-2023-0196","volume":"16","author":"W Xu","year":"2024","unstructured":"Xu W, Yang J, Ye S, et al. Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy Feb. 2024;16(3):131\u20134. https:\/\/doi.org\/10.2217\/imt-2023-0196.","journal-title":"Immunotherapy Feb"},{"key":"7852_CR25","doi-asserted-by":"publisher","unstructured":"Xu W, Lu J, Liu WR, et al. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma. J Immunother Cancer. 2023 Dec;1(12). https:\/\/doi.org\/10.1136\/jitc-2023-006667.","DOI":"10.1136\/jitc-2023-006667"},{"issue":"1","key":"7852_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/07357907.2022.2136684","volume":"41","author":"A Giatromanolaki","year":"2023","unstructured":"Giatromanolaki A, Chatzipantelis P, Contrafouris CA, Koukourakis MI. Tertiary lymphoid Structures, immune Response, and prognostic relevance in Non-Small cell lung cancer. Cancer Invest Jan. 2023;41(1):48\u201357. https:\/\/doi.org\/10.1080\/07357907.2022.2136684.","journal-title":"Cancer Invest Jan"},{"issue":"1","key":"7852_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12967-025-06510-6","volume":"9","author":"J Chen","year":"2025","unstructured":"Chen J, Yang Y, Luan S, Xu W, Gao Y. Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression. J Transl Med May. 2025;9(1):528. https:\/\/doi.org\/10.1186\/s12967-025-06510-6.","journal-title":"J Transl Med May"},{"issue":"7","key":"7852_CR28","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"1","author":"C Germain","year":"2014","unstructured":"Germain C, Gnjatic S, Tamzalit F, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med Apr. 2014;1(7):832\u201344. https:\/\/doi.org\/10.1164\/rccm.201309-1611OC.","journal-title":"Am J Respir Crit Care Med Apr"},{"issue":"5","key":"7852_CR29","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.xcrm.2022.100620","volume":"17","author":"LJ Sudmeier","year":"2022","unstructured":"Sudmeier LJ, Hoang KB, Nduom EK, et al. Distinct phenotypic States and Spatial distribution of CD8(+) T cell clonotypes in human brain metastases. Cell Rep Med May. 2022;17(5):100620. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100620.","journal-title":"Cell Rep Med May"},{"issue":"1","key":"7852_CR30","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"8","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun May. 2020;8(1):2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1.","journal-title":"Nat Commun May"},{"issue":"4","key":"7852_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/BLC-170120","volume":"27","author":"M Koti","year":"2017","unstructured":"Koti M, Xu AS, Ren KYM, et al. Tertiary lymphoid structures associate with tumour stage in urothelial bladder cancer. Bladder Cancer Oct. 2017;27(4):259\u201367. https:\/\/doi.org\/10.3233\/BLC-170120.","journal-title":"Bladder Cancer Oct"},{"issue":"5","key":"7852_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jclinpath-2015-203089","volume":"69","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Park IA, Song IH, et al. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. J Clin Pathol May. 2016;69(5):422\u201330. https:\/\/doi.org\/10.1136\/jclinpath-2015-203089.","journal-title":"J Clin Pathol May"},{"issue":"7","key":"7852_CR33","doi-asserted-by":"publisher","first-page":"e2410998","DOI":"10.1002\/advs.202410998","volume":"12","author":"J Lin","year":"2025","unstructured":"Lin J, Jiang S, Chen B, et al. Tertiary lymphoid structures are linked to enhanced antitumor immunity and better prognosis in Muscle-Invasive bladder cancer. Adv Sci (Weinh) Feb. 2025;12(7):e2410998. https:\/\/doi.org\/10.1002\/advs.202410998.","journal-title":"Adv Sci (Weinh) Feb"},{"issue":"12","key":"7852_CR34","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1021\/acsnano.4c01180","volume":"26","author":"G Kuang","year":"2024","unstructured":"Kuang G, Zhang Q, Li W, Zhao Y. Biomimetic tertiary lymphoid structures with microporous annealed particle scaffolds for cancer postoperative therapy. ACS Nano Mar. 2024;26(12):9176\u201386. https:\/\/doi.org\/10.1021\/acsnano.4c01180.","journal-title":"ACS Nano Mar"},{"issue":"8","key":"7852_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/1744666X.2024.2380892","volume":"20","author":"M Langouo Fontsa","year":"2024","unstructured":"Langouo Fontsa M, Padonou F, Willard-Gallo K. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy. Expert Rev Clin Immunol Aug. 2024;20(8):839\u201347. https:\/\/doi.org\/10.1080\/1744666X.2024.2380892.","journal-title":"Expert Rev Clin Immunol Aug"},{"key":"7852_CR36","doi-asserted-by":"publisher","first-page":"105154","DOI":"10.1016\/j.ebiom.2024.105154","volume":"104","author":"WP Lin","year":"2024","unstructured":"Lin WP, Li H, Sun ZJ. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle. EBioMedicine Jun. 2024;104:105154. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105154.","journal-title":"EBioMedicine Jun"},{"issue":"1","key":"7852_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41698-025-01012-6","volume":"1","author":"Y Lin","year":"2025","unstructured":"Lin Y, Yu Y, Wang Q, et al. Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer. NPJ Precis Oncol Jul. 2025;1(1):216. https:\/\/doi.org\/10.1038\/s41698-025-01012-6.","journal-title":"NPJ Precis Oncol Jul"},{"issue":"1","key":"7852_CR38","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1186\/s12967-024-05867-4","volume":"27","author":"X Liu","year":"2024","unstructured":"Liu X, Xu D, Zhou C, et al. Association of PD-1\u2009+\u2009Treg\/PD-1\u2009+\u2009CD8 ratio and tertiary lymphoid structures with prognosis and response in advanced gastric cancer patients receiving preoperative treatment. J Transl Med Dec. 2024;27(1):1152. https:\/\/doi.org\/10.1186\/s12967-024-05867-4.","journal-title":"J Transl Med Dec"},{"key":"7852_CR39","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3389\/fimmu.2019.01884","volume":"10","author":"A Maoz","year":"2019","unstructured":"Maoz A, Dennis M, Greenson JK. The Crohn\u2019s-Like lymphoid reaction to colorectal cancer-Tertiary lymphoid structures with Immunologic and potentially therapeutic relevance in colorectal cancer. Front Immunol. 2019;10:1884. https:\/\/doi.org\/10.3389\/fimmu.2019.01884.","journal-title":"Front Immunol"},{"issue":"6","key":"7852_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","volume":"17","author":"L Munoz-Erazo","year":"2020","unstructured":"Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA. Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol Immunol Jun. 2020;17(6):570\u20135. https:\/\/doi.org\/10.1038\/s41423-020-0457-0.","journal-title":"Cell Mol Immunol Jun"},{"issue":"12","key":"7852_CR41","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"14","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, et al. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity Dec. 2021;14(12):2812\u2013e28244. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.003.","journal-title":"Immunity Dec"},{"key":"7852_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2025.06.003","author":"Z Wang","year":"2025","unstructured":"Wang Z, Ge Q, Mo R, et al. Spatial and maturity heterogeneity of tertiary lymphoid structures shapes immune microenvironment and progression in prostate cancer. J Natl Cancer Cent. 2025. https:\/\/doi.org\/10.1016\/j.jncc.2025.06.003. \/07\/24\/ 2025;doi:.","journal-title":"J Natl Cancer Cent"},{"issue":"11","key":"7852_CR43","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1158\/2326-6066.CIR-20-0432","volume":"8","author":"AB Rodriguez","year":"2020","unstructured":"Rodriguez AB, Engelhard VH. Insights into Tumor-Associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy. Cancer Immunol Res Nov. 2020;8(11):1338\u201345. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0432.","journal-title":"Cancer Immunol Res Nov"},{"key":"7852_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejca.2021.03.054","volume":"151","author":"M Rouanne","year":"2021","unstructured":"Rouanne M, Arpaia N, Marabelle A. CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer. Eur J Cancer Jul. 2021;151:245\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2021.03.054.","journal-title":"Eur J Cancer Jul"},{"issue":"1","key":"7852_CR45","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.medj.2024.10.023","volume":"10","author":"F Peyraud","year":"2025","unstructured":"Peyraud F, Guegan JP, Vanhersecke L, et al. Tertiary lymphoid structures and cancer immunotherapy: from bench to bedside. Med Jan. 2025;10(1):100546. https:\/\/doi.org\/10.1016\/j.medj.2024.10.023.","journal-title":"Med Jan"},{"issue":"1","key":"7852_CR46","doi-asserted-by":"publisher","first-page":"e70046","DOI":"10.1111\/imr.70046","volume":"332","author":"J Rochefort","year":"2025","unstructured":"Rochefort J, Marodon G, Teillaud JL, Dieu-Nosjean MC. The sunrise of tertiary lymphoid structures in cancer. Immunol Rev Jul. 2025;332(1):e70046. https:\/\/doi.org\/10.1111\/imr.70046.","journal-title":"Immunol Rev Jul"},{"key":"7852_CR47","doi-asserted-by":"publisher","unstructured":"Zhao YY, Fan Z, Tao BR, Du ZG, Shi ZF. Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis. J Immunother Cancer. 2024 Jul;27(7). https:\/\/doi.org\/10.1136\/jitc-2024-009232.","DOI":"10.1136\/jitc-2024-009232"},{"issue":"6576","key":"7852_CR48","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"7","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science Jan. 2022;7(6576):eabf9419. https:\/\/doi.org\/10.1126\/science.abf9419.","journal-title":"Science Jan"},{"issue":"9","key":"7852_CR49","doi-asserted-by":"publisher","first-page":"116250","DOI":"10.1016\/j.celrep.2025.116250","volume":"23","author":"X Li","year":"2025","unstructured":"Li X, Chu X, Xu W, et al. Integrated Spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structures. Cell Rep Sep. 2025;23(9):116250. https:\/\/doi.org\/10.1016\/j.celrep.2025.116250.","journal-title":"Cell Rep Sep"},{"issue":"8","key":"7852_CR50","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell Aug. 2024;12(8):1370\u2013e13859. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006.","journal-title":"Cancer Cell Aug"},{"issue":"7","key":"7852_CR51","doi-asserted-by":"publisher","first-page":"102200","DOI":"10.1016\/j.xcrm.2025.102200","volume":"15","author":"SX Liu","year":"2025","unstructured":"Liu SX, Wu TW, Luo DH, et al. Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma. Cell Rep Med Jul. 2025;15(7):102200. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102200.","journal-title":"Cell Rep Med Jul"},{"key":"7852_CR52","doi-asserted-by":"publisher","unstructured":"Zubkova E, Kalinin A, Beloglazova I, et al. Artificial tertiary lymphoid structures: exploring mesenchymal stromal cells as a platform for immune niche formation. Int J Mol Sci. 2024 Dec;11(24). https:\/\/doi.org\/10.3390\/ijms252413286.","DOI":"10.3390\/ijms252413286"},{"issue":"23","key":"7852_CR53","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/0008-5472.CAN-23-2716","volume":"84","author":"D An","year":"2024","unstructured":"An D, Chen G, Cheng WY, et al. LTbetaR agonism promotes antitumor immune responses via modulation of the tumor microenvironment. Cancer Res Dec 2. 2024;84(23):3984\u20134001. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2716.","journal-title":"Cancer Res Dec 2"},{"issue":"803","key":"7852_CR54","doi-asserted-by":"publisher","first-page":"eado8395","DOI":"10.1126\/scitranslmed.ado8395","volume":"18","author":"Z Mi","year":"2025","unstructured":"Mi Z, Chen J, Zhang Z, et al. Synthetic biology-driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer. Sci Transl Med Jun. 2025;18(803):eado8395. https:\/\/doi.org\/10.1126\/scitranslmed.ado8395.","journal-title":"Sci Transl Med Jun"},{"issue":"10","key":"7852_CR55","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","volume":"10","author":"WH Fridman","year":"2023","unstructured":"Fridman WH, Meylan M, Pupier G, Calvez A, Hernandez I, Sautes-Fridman C. Tertiary lymphoid structures and B cells: an intratumoral immunity cycle. Immunity Oct. 2023;10(10):2254\u201369. https:\/\/doi.org\/10.1016\/j.immuni.2023.08.009.","journal-title":"Immunity Oct"},{"issue":"8","key":"7852_CR56","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke L, Brunet M, Guegan JP, et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat Cancer Aug. 2021;2(8):794\u2013802. https:\/\/doi.org\/10.1038\/s43018-021-00232-6.","journal-title":"Nat Cancer Aug"},{"issue":"1","key":"7852_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","volume":"6","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu M, Ren Y, et al. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Mol Cancer Apr. 2024;6(1):75. https:\/\/doi.org\/10.1186\/s12943-024-01980-6.","journal-title":"Mol Cancer Apr"},{"key":"7852_CR58","doi-asserted-by":"publisher","unstructured":"Zou J, Zhang Y, Zeng Y, et al. Tertiary lymphoid structures: a potential biomarker for anti-cancer therapy. Cancers (Basel). 2022 Dec;2(23). https:\/\/doi.org\/10.3390\/cancers14235968.","DOI":"10.3390\/cancers14235968"},{"issue":"11","key":"7852_CR59","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"11","author":"IP MacFawn","year":"2024","unstructured":"MacFawn IP, Magnon G, Gorecki G, et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell Nov. 2024;11(11):1864\u2013e18815. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.007.","journal-title":"Cancer Cell Nov"},{"issue":"8","key":"7852_CR60","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.21873\/anticanres.17184","volume":"44","author":"S Nohira","year":"2024","unstructured":"Nohira S, Kuramitsu S, Ohno M, et al. Tertiary lymphoid structures in brain metastases of lung cancer: prognostic significance and correlation with clinical outcomes. Anticancer Res Aug. 2024;44(8):3615\u201321. https:\/\/doi.org\/10.21873\/anticanres.17184.","journal-title":"Anticancer Res Aug"},{"issue":"1","key":"7852_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00428-023-03577-8","volume":"483","author":"T Karjula","year":"2023","unstructured":"Karjula T, Niskakangas A, Mustonen O, et al. Tertiary lymphoid structures in pulmonary metastases of microsatellite stable colorectal cancer. Virchows Arch Jul. 2023;483(1):21\u201332. https:\/\/doi.org\/10.1007\/s00428-023-03577-8.","journal-title":"Virchows Arch Jul"},{"issue":"9","key":"7852_CR62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC. Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer Sep. 2024;24(9):629\u201346. https:\/\/doi.org\/10.1038\/s41568-024-00728-0.","journal-title":"Nat Rev Cancer Sep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07852-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:42:16Z","timestamp":1774280536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07852-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7852"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07852-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Fudan University Shanghai Cancer Center (Approval Number: 2409305-10). Written informed consent was waived due to the retrospective nature of the study and the use of re-identified archival specimens.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"396"}}